Recent Editorials
Why Industry Must Design Alzheimer’s Trials To Include People With Down Syndrome
Read More
News/Press Release
Síndrome de Down y Alzheimer: ¿Cómo se relacionan?


Recent Editorials
Down syndrome families’ fight for access to Alzheimer’s trials, treatments
October 10, 2023

Recent Editorials
Alzheimer’s meds are here. But for the Down syndrome community, it’s still the 1980s
March 1, 2023


